To the Editors of The Crimson:
So that your readers may be properly and fairly informed regarding the recombinant DNA (gene transplant) research controversy, it is important that your newspaper make available to them the following pertinent information.
When scientists are described to newspaper readers as Nobel Laureates affiliated with a prestigious institution, their views are received as those of honored, impartial scientists. It is therefore essential for realistic evaluation of such views that readers know of the commercial connections of Dr. David Baltimore and Dr. Salvador Luria: both are listed as consultants in the brochure of Collaborative research, of Waltham, a company that manufactures products employed in the assay of restriction enzymes used in recombinant DNA research. Francine Robinson Simring, Chairman Committee for Genetics
Read more in News
Lavish Sparks Yale Past Engineers, 4-1Recommended Articles
-
Gene EnvyM ICHAEL ROGERS WAS there, well, almost from the beginning. He struggled through genetics textbooks while other journalists read UPI
-
Juggling With GenesLast week a Harvard scientist won the Nobel Prize for Physics. While the scientific community applauded the award, the significance
-
Rosovsky Approves DNA Research LabDean Rosovsky yesterday asked the Corporation to authorize construction of a laboratory for research on recombinant DNA. Several Harvard biologists
-
Behind the Genetics ControversyWhy care about recombinant DNA? John Lear's new book explains passionately and convincingly why people who don't know the first
-
DNA: There is Time to ThinkT HE CAMBRIDGE EXPERIMENTATION REVIEW BOARD is currently weighing the benefits and costs of allowing Harvard and MIT to proceed
